BOSTON, March 22, 2018 /PRNewswire/ — FinMason, a rapidly growing FinTech company and leading provider of investment analytics as a service, today announced the appointment of industry veteran David Remstein as president and chief operating officer. In the newly formed position, Remstein will drive planning and manage the growth of the company in terms of personnel, clients, products and geographies. Remstein will help guide FinMason as they seek to grow their investment analytics offering from roughly 700 different analytics to more than 1,400 and include sophisticated analyses on private securities and global, multi-asset portfolios.
“We are in a period of tremendous growth: five months ago, we were 12 people. Today, we have grown to 30 to keep pace with client demands. By the end of the year, we anticipate being more than 50 and operating in 12 countries,” stated Kendrick Wakeman, founder and CEO. “David has extensive experience operating globally, thinking strategically and leading successfully. He is the perfect person to help execute our business plan and capitalize on our current product advantage.”
Prior to joining FinMason, Remstein served as the global head of buy-side financial consulting at Riskcare Inc. Remstein has held a variety of roles over his 32-year career in financial services, including global head of client reporting at Citi Private Bank, global head of investment performance at J.P. Morgan Asset Management, and global product head and chief operating officer of investment analytics & consulting at J.P. Morgan Corporate Investment Bank.
“The analytics engine FinMason has developed is delivering the speed, scope and flexibility that firms in the industry need to be competitive, but struggle to build, in the current environment,” remarked Remstein. “I am excited to join FinMason’s visionary leadership team as the firm continues its path toward delivering the best-in-class solution and service.”
Remstein earned his M.B.A. in business and finance at Pace University and his B.S. in business economics at the State University of New York at Oneonta. He began his role at FinMason on March 21.